Clinical trials

  • Protein - Other for Moderate-severe atopic dermatitis | Atopic dermatitis
  • ALECTINIB for ALK fusion-positive solid tumors | ALK fusion-positive primary CNS tumors
  • XmAb24306 for Relapsed/Refractory Multiple Myeloma|Multiple myeloma
  • GUSELKUMAB for Psoriatic arthritis
  • JNJ-87189401 for Advanced prostate cancer | Prostate cancer | Metastatic prostate cancer | Hormone-refractory prostate cancer
  • LENVATINIB for Advanced esophageal squamous cell carcinoma
  • AG13909 for Cushing's disease
  • PEMBROLIZUMAB for Cervical HSIL (CIN 2-3) | Vulvar intraepithelial neoplasia (VIN 2-3)
  • TRASTUZUMAB DERUXTECAN for HER2-expressing tumors
  • Clinical trial in Non-Hodgkin lymphoma | B-cell non-Hodgkin lymphoma
  • CAMIZESTRANT for Early breast cancer (ER-positive, HER2-negative)
  • GUSELKUMAB for Ulcerative colitis|Moderately to severely active ulcerative colitis